
Breast Care
On this page
Why choose UCSF Health for breast care and breast cancer treatment?
UCSF Health is a leader in early detection, advanced treatments, innovative surgeries and groundbreaking research for breast cancer. We're known regionally and nationally for our breast cancer expertise and comprehensive team of breast surgeons, plastic and reconstructive surgeons, breast oncologists and specialized nurse practitioners. We provide all the personalized services and compassionate support you need to improve your quality of life at every stage of your journey.
Why choose UCSF Health for breast care and breast cancer treatment?
UCSF Health is a leader in early detection, advanced treatments, innovative surgeries and groundbreaking research for breast cancer. We're known regionally and nationally for our breast cancer expertise and comprehensive team of breast surgeons, plastic and reconstructive surgeons, breast oncologists and specialized nurse practitioners. We provide all the personalized services and compassionate support you need to improve your quality of life at every stage of your journey.
Integrated team
Patients and their families receive whole-person care from doctors, genetic counselors, psychologists, social workers and nutritionists.Convenient access
With breast care locations across the Bay Area, it's easy to find exceptional care close to where you live and work.Nurse navigators
Our experienced nurse navigators guide you through breast cancer diagnosis, offering support and helping you understand your next steps.Clinical trials
UCSF Health is a national leader in breast cancer research. Our patients have access to the most promising new treatments through clinical trials.
Our breast care services
Whether you're dealing with concerning symptoms, a new breast cancer diagnosis, advanced cancer or other breast health issues, we offer all the services you need for better breast health. Our team provides education and guidance every step of the way, empowering you to make the best decisions for your needs.
Breast cancer prevention
If you have an increased risk for breast cancer due to family history or genetics, we provide genetic counseling, screening recommendations and risk-management strategies. Learn more about our breast cancer prevention services.
Early detection and diagnosis
We focus on detecting breast cancer as early as possible, when treatment is more effective. Our experts use the latest breast imaging techniques, including 3D mammography, breast MRI and ultrasound-guided breast biopsies. If you have abnormal mammogram results or a breast lump, we can provide coordinated diagnostic evaluation that includes an expedited breast biopsy.
Personalized breast cancer treatments
A team of medical and radiation oncologists, breast surgeons, plastic and reconstructive surgeons, radiologists and pathologists works together to plan your care. From the latest targeted therapies to advanced breast reconstruction, you'll find a wide range of innovative treatment options. Learn more about our expertise in breast cancer.
Comprehensive support services
At UCSF Health, we understand that complete breast care means meeting your physical, emotional and spiritual needs. You'll find a wide range of support services designed to help you and your family heal, including:
Cancer support services, including support groups and nutrition and exercise counseling
Integrative health services that focus on holistic wellness
Cancer symptom management, including treatment and counseling for cancer-related health issues
Fertility preservation services, including education and care from reproductive endocrinologists
Lymphedema prevention and care before and after breast surgery
Long-term follow-up care and support for cancer survivors
Locations
Providers
Excellence in patient care

Best in California and No. 7 in the nation for cancer care
Related conditions & treatments
Conditions
- Abnormal Mammogram
- Atypical Ductal Hyperplasia
- Atypical Lobular Hyperplasia
- BRCA
- Breast Cancer
- Breast Lump
- Nipple Discharge
Treatments
- Biological Targeted Therapy
- Breast Biopsy
- Breast Reconstruction
- Breast Surgery
- Cancer Prevention
- Clinical Trials
- Fertility Preservation
- Genetic Counseling
Clinical trials
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXdOpens in a new window
Objective response rate (ORR), defined as best overall response of either complete or partial response, will be assessed among participants who start protocol therapy and have measurable disease at screening.MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesOpens in a new window
Create a large scale registry of full genome expression data with clinical data to investigate possible new gene associations with prognostic or predictive value.UCSF Biobank for Hereditary Cancers and Tumor-Associated MutationsOpens in a new window
Participant-derived models may include (but are not limited to) xenografts (PDX), organoids (PDO), and cell lines (PDCLs). These models recapitulate the biology and tissue context of the original tumors from which they are derived...Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)Opens in a new window
Feasibility is defined as enrollment of 10-12 patients with metastatic ILC in the first 2 years across all participating sites, and collection of clinical assessments in >=75% of treating medical oncologists.A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceOpens in a new window
Assessed by the time from date of randomization to the date of first occurrence of: - Ipsilateral invasive breast tumor recurrence - Local/regional invasive breast cancer recurrence - Distant recurrence - Contralat...A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerOpens in a new window
IDFS excluding second non-breast primary invasive cancers.Pilot Study of Pancreatic Cancer ScreeningOpens in a new window
Proportion of participants with an abnormal MRI finding will be reported as an event. An estimated event rate of 19% in participants with a strong family history (FH) of pancreatic cancer and 10% in those participants without a st...Prospective Registry of ADC as First- and Second-line Treatment for Breast CancerOpens in a new window
rwPFS is defined as the amount of time that elapses between the initiation of ADC1 therapy until the patient experiences disease progression, initiates subsequent anti-cancer therapy, completes study participation, or experiences...First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsOpens in a new window
Study STX-478-101 (LY4064809) is a multipart, open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of STX-478 (LY4064809) in participants with advanced solid tumors with P13Ka mutations.Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair DeficiencyOpens in a new window
Month 36 is assumed to be study end. Incidence and severity of AEs and SAEs by treatment group, including changes in vital signs, electrocardiograms (ECGs) and laboratory results qualifying and reported as AEs.
Accreditations & memberships

National Cancer Institute
The National Cancer Institute has designated UCSF Health a comprehensive cancer center, its highest ranking. This designation is awarded to centers that demonstrate scientific excellence and the ability to conduct cancer research across many disciplines.
Commission on Cancer
UCSF Health's cancer programs have been accredited by the American College of Surgeons' Commission on Cancer (CoC) since 1933. The CoC is a consortium of groups dedicated to improving cancer patients' survival and quality of life via research, education and better medical care.
National Comprehensive Cancer Network
UCSF is a member of the National Comprehensive Cancer Network, an alliance of the world's top cancer centers. The network brings together leaders in treatment and research to improve the quality, effectiveness and efficiency of cancer care.
Research initiatives
Athena Breast Health NetworkOpens in a new window
The Athena Breast Health Network, a collaborative organization that includes UCSF, promotes data sharing to help all partners deliver more effective and personalized care to patients with breast cancer.Breast Cancer TrialsOpens in a new window
BreastCancerTrials.org helps match patients who want to participate in breast cancer research with open studies that are right for them.UCSF Helen Diller Family Comprehensive Cancer Center ResearchOpens in a new window
UCSF is home to a range of research initiatives aimed at improving outcomes for cancer patients everywhere. This includes research on topics such as immunotherapy, BRCA mutations and molecular diagnostic testing.
Guides and forms

Cutting-edge breast cancer care
Recommended reading
Special programs

Breast Cancer Coordinated Diagnostic Evaluation
We provide prompt breast biopsies and diagnoses for people with abnormal mammograms or breast lumps. Our streamlined services give you the answers you need.
Mammography & Breast Imaging
Our experienced radiology team offers the latest breast imaging techniques, including 3D digital mammography and breast MRI.

















